Somewhere in a hospital corridor this week, a patient will be handed a tablet and asked to rate their care before they have even left the ward. The request feels routine, almost incidental to the business of getting better. But behind that single survey sits an industry moving quickly to make such feedback usable, a national policy that now treats patient experience as central to reform, and a small number of suppliers positioning themselves to be the ones who can actually deliver on that ambition.

Radar Healthcare's acquisition of Cemplicity, announced this month, sits squarely in that space. The Leeds-based quality, risk and compliance specialist, backed by Marlin Equity Partners, has added a patient experience and outcomes platform that brings established capabilities in PREMs, PROMs, real-time feedback and shared decision-making. It is the company's second acquisition in eighteen months, following the purchase of EIDO Healthcare, a digital consent and patient information provider, and together the moves build something coherent: consent captured before care, feedback gathered during and after it, and both feeding into the governance and improvement workflows that trusts already rely on Radar for. Executives on both sides described the aim as connecting what patients experience with the action needed to respond to it, which is a fair description of a genuine gap in how most NHS organisations currently operate.

That gap has become more consequential this year. The 10 Year Health Plan commits the NHS to collecting patient-reported experience and outcome measures in a more systematic and comparable way, expanding their use well beyond the niche clinical settings where PROMs have traditionally lived. It proposes patient power payments, under which providers could see part of their payment linked to whether patients report being satisfied with their care, a new National Director of Patient Experience, and a Patient Choice Charter that will let people compare providers using feedback and outcomes data through the NHS App. None of this is deliverable without software that can capture patient voice at scale and route it into workflows that produce real changes on the ward, rather than reports that sit in a folder.

This is where the practical value of the Radar and Cemplicity combination becomes clearer. Much of the NHS's patient-facing technology has grown up trust by trust and ICB by ICB, procured against local specifications and local budgets, with Humber and North Yorkshire's recent contract with a separate patient portal provider as one example of a landscape that still runs on many parallel systems. A platform that can plausibly link consent, in-care feedback and post-care outcomes into a single governance and improvement pathway offers trusts a route out of that fragmentation, provided the integration lives up to the ambition set out in the announcement. For NHS leaders under pressure to demonstrate measurable improvement against the productivity and quality metrics that now sit at the centre of national policy, a supplier able to close that loop end to end is solving a real operational problem rather than adding another point solution to an already crowded digital estate.

The wider test, as with any acquisition, will be delivery: whether the combined platform genuinely simplifies what trusts have to manage, and whether the data it generates is robust enough to support the comparative and financial uses the 10 Year Health Plan envisages. Marlin's continued backing gives Radar the resources to invest in that integration properly rather than treating it as a badge exercise, and a Leeds-based business building this kind of capability domestically, rather than importing it, is itself a point in the sector's favour at a moment when the government is explicit about wanting UK life sciences and health-tech firms to grow alongside NHS reform.

What the deal ultimately signals is a supplier reading the policy direction correctly and building towards it in advance, rather than reacting to a mandate once it lands. As patient experience moves from a quality footnote to a genuine input into how the NHS is judged and funded, the organisations that already hold the infrastructure to capture, connect and act on that data will be the ones NHS leaders turn to first.